If a company's business model is durable and proven to be all-weather by years of strong performance, it won't be at risk for as many problems when things get dicey. In this vein, there are three such companies that investors should know about and consider buying today. Vertex Pharmaceuticals (NASDAQ: VRTX) is one of the world's largest biopharma companies, and its long-standing focus on developing and commercializing medicines for cystic fibrosis (CF), a rare hereditary pulmonary disease, is what makes it so formidable.
Jharonne Martis, London Stock Exchange Group Director of Consumer Research, joins Yahoo Finance Live to discuss the state of the retail industry, the outlook on mall retailers, travel spending, and Amazon Prime Day.
Julie Biel, Portfolio Manager at Kayne Anderson Rudnick, joins Yahoo Finance Live to discuss how to forecast economic outlooks after downturns in retailers, travel demands, and defensively investing into the health care space.